Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  221.27
-1.29 (-0.58%)
AAPL  271.84
-2.77 (-1.01%)
AMD  198.11
-11.06 (-5.29%)
BAC  54.55
-0.26 (-0.47%)
GOOG  298.06
-9.67 (-3.14%)
META  649.41
-7.74 (-1.18%)
MSFT  476.12
-0.27 (-0.06%)
NVDA  170.94
-6.78 (-3.81%)
ORCL  178.46
-10.19 (-5.40%)
TSLA  467.21
-22.67 (-4.63%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.